Test immunoglobulin treatment for fatigue in multiple sclerosis
Part of Blood & lymphatic, Brain & nervous system, Immune system & allergy clinical trials.
This trial studies whether giving immunoglobulins (antibody medicines) can improve fatigue in people with multiple sclerosis (MS). It will enroll only people whose MS and fatigue are stable and meet specific blood/health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple sclerosis (MS) using the 2017 McDonald criteria
- You are between 18 and 65 years old
- Your MS has been stable in the last 12 months (no relapse symptoms and no new MRI activity, and disability not worsening)
- Your MS treatment (immunotherapy) has not changed in the last 12 months
- You can walk without major help (EDSS score less than 4)
- You can sign a written consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high intensity exercise can improve both movement and thinking in people with multiple sclerosis. It might help if you can walk but need some support for balance.
This trial tests a brain stimulation therapy designed to reduce fatigue in people with multiple sclerosis. If you experience moderate to severe fatigue and have a stable medication routine, this study might help determine if a non-invasive treatment can improve your energy levels.
This trial tests whether a virtual reality headset that uses gamma sensory stimulation can help reduce fatigue in people with multiple sclerosis. You would use the headset at home and report your fatigue levels.
This early phase trial tests a new treatment called GC012F for people with multiple sclerosis. It aims to see how safe and tolerable it is, and may offer a new option for those whose current treatments are not working well enough.
This trial tests an online self-management program to help reduce fatigue in people with MS. You'll use a website or app over 24 weeks, and researchers will check how well it works.
This study will test different parts of cognitive behavioral therapy to see which ones help with fatigue in people with multiple sclerosis. You will participate in sessions that may involve changing thoughts about fatigue, scheduling activities, or addressing related emotions like depression or anxiety.
Hear when a new Hypogammaglobulinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.